Wuxi Beta Conquer Isotope Labeling Key Technology Assistant New Drug Research and Development

March 21, 2019 11:10:13 Source: Wuxi Beta Pharmaceutical Technology Co., Ltd.

Website:http://www.js.xinhuanet.com/2019-03/21/c_1124263801.htm

Recently, Wuxi Beta Pharmaceutical Technology Co., Ltd., located in Jiangyin High-tech Zone, Jiangsu Province, signed a scientific and technological service cooperation agreement with Sichuan Kelun Pharmaceutical Research Institute. The head of the new drug research and development department of the hospital recognized Wuxi Beta's radioisotope labeling work and believed that Wuxi BetaIn 2018, the three small molecular compounds labeled with carbon 14(C-14) and tritium (H-3) isotopes for Sichuan Kelun Pharmaceutical Research Institute are more efficient, cheaper and more convenient to communicate than similar foreign products. We are willing to establish a long-term cooperative relationship with Wuxi Beta.

In 2018, Wuxi Beta provided more than 10 successful marks of new drugs for Sichuan Kelun Pharmaceutical Research Institute, Jiangsu Hengrui Pharmaceutical, Jiangsu Haosen Pharmaceutical, Nanjing Shenghe Pharmaceutical, Beijing Sailintai Pharmaceutical, Fujian Haixi Pharmaceutical and other leading pesticide research and development enterprises, and Qingdao Qingyuan and other leading pesticide research and development enterprises, which were well received by customers.

Isotope labeling is an important aspect of the peaceful use of nuclear energy, and it is also an important part of the nuclear industry serving medicine, pesticides, environmental protection industries, the national economy and people's lives. With the discovery of heavy hydrogen isotopes and artificial radionuclides, isotope tracer method is widely used in life science, medicine, chemistry and other fields. Wuxi Beta Pharmaceutical Technology Co., Ltd., founded by Dr. Li Gang, the second prize winner of the National Science and Technology Progress Award and a returned entrepreneur from the United States, entered the Biomedical Industrial Park of Jiangyin High-tech Zone in November 2008. It is a professional carbon 14, carbon 13, etc. A leading company in the research and development and labeling services of isotope labeled compounds. The company's main direction is to provide "high, fine, lack" carbon 14, carbon 13 and other isotope labeled tracer technology services for medicine, pesticide research and development industry and medical testing industry, so as to carry out drug generation, clinical, environmental research and disease testing.

Ten years to grind a sword, the bench can sit ten years cold. The Wuxi Beta R & D team with Dr. Li Gang as the core, with the enthusiastic help and guidance of academician Zhou Yongmao and other industry experts in the field of nuclear engineering, and with the support of Jiangyin Science and Technology Fund, Wuxi Leading Talent Plan, Changsha High-level Talent Plan, Jiangsu Science and Technology Support Plan and the Innovation Fund of the Ministry of Science and Technology, has focused on research and development for ten years, solving the bottleneck problem of preparation and supply of carbon 14 source materials and labeled precursor compounds; overcame the technical difficulties in the preparation and labeling of key compounds labeled with carbon 14, and realized the localization of urea-14C and urea-13C, the key raw materials used as the "gold standard" for the detection of Helicobacter pylori in the stomach. At the same time, it also conquered the preparation technology of isotope internal standard for neonatal genetic metabolic disease screening and vitamin D deficiency detection, breaking a number of international import restrictions at one stroke and realizing domestic substitution. Not only that, in the field of carbon 14, Wuxi Beta has all the technologies of the entire industrial chain of "source materials-labeling precursor compounds-labeling service technology". This advantage can become a reliable labeling service partner for pharmaceutical and pesticide development enterprises and a strong backing to ensure their innovative development. Wuxi Beta is also planning to enter the United States and other international markets, for foreign enterprises to provide a full range and shortage of isotope labeling products and tracer technology services, is committed to building an international leading enterprises in the field of carbon 14 labeling.

In 2019, Wuxi Beta will strive for progress in stability and take advantage of the situation. Relying on the technical support and resources of Nobel Prize Research Institute, academician workstations and cooperative units, Wuxi Beta will vigorously develop isotope labeling technologies such as carbon 14(C-14), carbon 13(C-13), tritium (H-3), deuterium (H-2) and nitrogen 15(N-15) to build an international C- 14 labeling service leader and a domestic C- 13 tracing detection leader, in order to realize the domestic substitution of imports, to help the pharmaceutical and pesticide industry research and development of new drugs, so that isotope atomic energy for the benefit of China's new medicine, new pesticide research and development and precision medical testing, for the benefit of human health and ecological environmental protection. (cao weiqiu)

Website:http://www.js.xinhuanet.com/2019-03/21/c_1124263801.htm